Gossamer Bio, Inc.

GOSS · Nasdaq · SIC 2834: Pharmaceutical Preparations
113
SEC Filings

Business Summary

. Overview We are a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, or PH, including pulmonary arterial hypertension, or PAH, and PH 3 Table of Contents associated with interstitial lung disease, or PH-ILD. Our goal is to be an industry leader in, and to enhance the lives of patients living with, PH. To accomplish this goal, we have assembled a deeply experienced and highly skilled group of indu...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGOSSdiscussed_in_filing Cybersecurity
topic_mentionGOSSdiscussed_in_filing Trusted Computing
topic_mentionGOSSdiscussed_in_filing Blockchain & Crypto
topic_mentionGOSSdiscussed_in_filing Regulation
topic_mentionGOSSdiscussed_in_filing Healthcare & Bio
topic_mentionGOSSdiscussed_in_filing Sovereign & Government
topic_mentionGOSSdiscussed_in_filing Cybersecurity
topic_mentionGOSSdiscussed_in_filing Trusted Computing
topic_mentionGOSSdiscussed_in_filing Blockchain & Crypto
topic_mentionGOSSdiscussed_in_filing Regulation
topic_mentionGOSSdiscussed_in_filing Healthcare & Bio
topic_mentionGOSSdiscussed_in_filing Sovereign & Government
topic_mentionGOSSdiscussed_in_filing Cybersecurity
topic_mentionGOSSdiscussed_in_filing Trusted Computing
topic_mentionGOSSdiscussed_in_filing Blockchain & Crypto
topic_mentionGOSSdiscussed_in_filing Regulation
topic_mentionGOSSdiscussed_in_filing Healthcare & Bio
topic_mentionGOSSdiscussed_in_filing Sovereign & Government
topic_mentionGOSSdiscussed_in_filing Cybersecurity
topic_mentionGOSSdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001728117-26-000017EDGAR94K words
2025-03-132024-12-310001728117-25-000021EDGAR—
2024-03-052023-12-310001728117-24-000019EDGAR—
2023-03-172022-12-310001728117-23-000010EDGAR—
2022-03-032021-12-310001728117-22-000019EDGAR—
2021-02-262020-12-310001728117-21-000019EDGAR—
2020-03-242019-12-310001564590-20-012323EDGAR—
2019-03-222018-12-310001564590-19-009031EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001728117-25-000081EDGAR22K words
2025-08-052025-06-300001728117-25-000068EDGAR—
2025-05-152025-03-310001728117-25-000036EDGAR—
2024-11-072024-09-300001728117-24-000092EDGAR—
2024-08-122024-06-300001728117-24-000085EDGAR—
2024-05-072024-03-310001728117-24-000056EDGAR—
2023-11-092023-09-300001728117-23-000134EDGAR—
2023-08-082023-06-300001728117-23-000108EDGAR—
2023-05-092023-03-310001728117-23-000049EDGAR—
2022-11-032022-09-300001728117-22-000100EDGAR—
2022-08-092022-06-300001728117-22-000085EDGAR—
2022-05-102022-03-310001728117-22-000047EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001728117-26-000018EDGAR2K words
2026-02-230001728117-26-000004EDGAR—
2025-11-050001728117-25-000082EDGAR—
2025-09-250001728117-25-000076EDGAR—
2025-08-050001728117-25-000069EDGAR—
2025-06-250001728117-25-000043EDGAR—
2025-06-160001728117-25-000040EDGAR—
2025-05-150001728117-25-000037EDGAR—
2025-03-130001728117-25-000022EDGAR—
2025-02-190001728117-25-000004EDGAR—

113 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001728117
TickerGOSS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f1aa922c0434cf3cd91333ca6c7418fd5ffe3d6108fe82f27a65d8e7c998025a
parent: 1fe7079a1d1d598b933ed8b25442edf12c6f460066ec77a047585cdb98f131c1
content hash: d51cfae8aed9b36a44bc25b7b95c239f04e0d8ff49ed5095e491fb9a1d489177
signed: 2026-04-13T04:45:20.732Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf